Sang Cheul Oh
0000-0002-0527-6001
Publication & Citation Trends
Publications
0 total
Neoadjuvant docetaxel, oxaliplatin, and S-1 plus surgery and adjuvant S-1 for resectable advanced gastric cancer: Final survival outcomes of the randomized phase 3 PRODIGY trial.
Cited by 0
Semantic Scholar
Outcomes by antibiotic use in participants with advanced biliary tract cancer treated with durvalumab or placebo plus gemcitabine and cisplatin in the phase 3 TOPAZ-1 study.
Cited by 3
Semantic Scholar
Napabucasin plus nab-paclitaxel with gemcitabine versus nab-paclitaxel with gemcitabine in previously untreated metastatic pancreatic adenocarcinoma: an adaptive multicentre, randomised, open-label, phase 3, superiority trial OA
Cited by 28
Semantic Scholar
Zolbetuximab + CAPOX in 1L claudin-18.2+ (CLDN18.2+)/HER2− locally advanced (LA) or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma: Primary phase 3 results from GLOW.
Cited by 24
Semantic Scholar
A novel RIP1-mediated canonical WNT signaling pathway that promotes colorectal cancer metastasis via β -catenin stabilization-induced EMT OA
Cited by 17
Semantic Scholar
Health-related quality of life (HRQoL) in the phase 3 KEYNOTE-966 study of pembrolizumab (pembro) plus gemcitabine and cisplatin (gem/cis) versus placebo plus gem/cis for advanced biliary tract cancer (BTC).
Cited by 6
Semantic Scholar
Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial OA
Cited by 458
Semantic Scholar
Research Topics
Gastric Cancer Management and Outcomes
(99)
Cholangiocarcinoma and Gallbladder Cancer Studies
(52)
Colorectal Cancer Treatments and Studies
(49)
Hedgehog Signaling Pathway Studies
(40)
Lung Cancer Treatments and Mutations
(34)
Affiliations
Korea Development Institute
The University of Texas MD Anderson Cancer Center
University of Pittsburgh
University of Oregon
Korea University